Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.12B | 1.09B | 1.10B | 1.09B | 1.06B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12B | 1.09B | 1.10B | 1.09B | 1.06B |
| Cost of Revenue | 373.77M | 363.45M | 359.74M | 344.31M | 342.71M |
| Gross Profit | 749.67M | 724.29M | 738.02M | 745.95M | 715.69M |
| SG&A Expenses | 415.92M | 409.36M | 412.11M | 410.73M | 392.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.82M | -3.53M | -935.20K | -12.53M | -4.11M |
| Total Operating Expenses | 828.79M | 808.28M | 809.41M | 781.51M | 767.11M |
| Operating Income | 294.64M | 279.46M | 288.35M | 308.75M | 291.30M |
| Income Before Tax | 286.24M | -191.01M | 279.16M | 243.58M | 204.14M |
| Income Tax Expenses | 62.93M | -41.92M | 61.41M | 106.52M | 81.68M |
| Earnings from Continuing Operations | 223.31M | -149.10M | 217.74M | 137.07M | 122.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 223.31M | -149.10M | 217.74M | 137.07M | 122.45M |
| EBIT | 294.64M | 279.46M | 288.35M | 308.75M | 291.30M |
| EBITDA | 808.32M | 333.05M | 342.12M | 344.35M | 343.47M |
| EPS Basic | 0.99 | -0.66 | 0.97 | 0.61 | 0.54 |
| Normalized Basic EPS | 0.80 | 0.76 | 0.79 | 0.79 | 0.60 |
| EPS Diluted | 0.99 | -0.66 | 0.97 | 0.61 | 0.54 |
| Normalized Diluted EPS | 0.80 | 0.76 | 0.79 | 0.79 | 0.60 |
| Average Basic Shares Outstanding | 225.20M | 225.20M | 225.00M | 225.40M | 225.40M |
| Average Diluted Shares Outstanding | 225.20M | 225.20M | 225.00M | 225.40M | 225.40M |
| Dividend Per Share | 0.00 | 0.77 | -- | 2.82 | 0.00 |
| Payout Ratio | 77.02% | 0.00% | 290.41% | 0.00% | 140.00% |